PAYER POLICY CHANGES

J9219 Insurance Policy Changes

HCPCS J9219 is officially defined as "Leuprolide acetate implant, 65 mg." HCPCS J9219 is referenced in 10 tracked payer policy changes from BCBS Tennessee, Sentara Health Plans, and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J9219 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch J9219

Get one email when a payer policy names J9219, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for J9219

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J9219 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.